首页> 外文期刊>Human Genetics >Whole exome sequencing in dominant cataract identifies a new causative factor, CRYBA2, and a variety of novel alleles in known genes
【24h】

Whole exome sequencing in dominant cataract identifies a new causative factor, CRYBA2, and a variety of novel alleles in known genes

机译:在显性白内障中的整个外显子组测序可确定新的致病因素CRYBA2和已知基因中的多种新等位基因

获取原文
获取原文并翻译 | 示例
       

摘要

Pediatric cataracts are observed in 1-15 per 10,000 births with 10-25 % of cases attributed to genetic causes; autosomal dominant inheritance is the most commonly observed pattern. Since the specific cataract phenotype is not sufficient to predict which gene is mutated, whole exome sequencing (WES) was utilized to concurrently screen all known cataract genes and to examine novel candidate factors for a disease-causing mutation in probands from 23 pedigrees affected with familial dominant cataract. Review of WES data for 36 known cataract genes identified causative mutations in nine pedigrees (39 %) in CRYAA, CRYBB1, CRYBB3, CRYGC (2), CRYGD, GJA8 (2), and MIP and an additional likely causative mutation in EYA1; the CRYBB3 mutation represents the first dominant allele in this gene and demonstrates incomplete penetrance. Examination of crystallin genes not yet linked to human disease identified a novel cataract gene, CRYBA2, a member of the βγ-crystallin superfamily. The p.(Val50Met) mutation in CRYBA2 cosegregated with disease phenotype in a four-generation pedigree with autosomal dominant congenital cataracts with incomplete penetrance. Expression studies detected cryba2 transcripts during early lens development in zebrafish, supporting its role in congenital disease. Our data highlight the extreme genetic heterogeneity of dominant cataract as the eleven causative/likely causative mutations affected nine different genes, and the majority of mutant alleles were novel. Furthermore, these data suggest that less than half of dominant cataract can be explained by mutations in currently known genes.
机译:小儿白内障的患病率每10,000例中有1-15例,其中10-25%的病例是由遗传原因引起的;常染色体显性遗传是最常见的模式。由于特定的白内障表型不足以预测哪个基因被突变,因此利用全外显子组测序(WES)来同时筛选所有已知的白内障基因,并检查来自23个受​​家族感染的家系的先证者中致病突变的新候选因子。显性白内障。回顾WES数据,了解36个已知白内障基因,确定了CRYAA,CRYBB1,CRYBB3,CRYGC(2),CRYGD,GJA8(2)和MIP的9个系谱中的致突变,以及EYA1中的另一个可能的致病突变; CRYBB3突变代表该基因中的第一个优势等位基因,并显示出不完全的外显率。尚未与人类疾病相关的晶状体蛋白基因的检查鉴定出一种新的白内障基因CRYBA2,它是βγ-晶状体蛋白超家族的成员。 CRYBA2中的p。(Val50Met)突变与疾病表型在一个四代谱系中共同分离,该谱系具有常染色体显性先天性白内障且外显不全。表达研究在斑马鱼早期晶状体发育过程中检测到cryba2转录本,支持其在先天性疾病中的作用。我们的数据突出了优势性白内障的极端遗传异质性,因为十一个致病性/可能的致病性突变影响了九个不同的基因,而且大多数突变等位基因是新颖的。此外,这些数据表明,不到一半的优势性白内障可以用目前已知基因的突变来解释。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号